Q515--575 Anatomic Pathology Services per Statement of Work New 5 Year Blanket Purchase Agreement
Veterans Affairs · NETWORK CONTRACT OFFICE 19 (36C259)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25925Q0293 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
*It is estimated that the Request for Quote for the requirement below will be posted to Contract Opportunities on or about 05/01/2025* PERFORMANCE WORK STATEMENT for ANATOMIC PATHOLOGY SERVICES Western Colorado Health Care System (WCHCS) Grand Junction VA Medical Center 2121 North Avenue Grand Junction, CO. 81501 Background The purpose of this Statement of Work (SOW) is to procure Anatomic Pathology Services from a qualified Reference Laboratory (hereafter Contractor) for the Western Colorado Health Care System (WCHCS), Pathology and Laboratory Medicine Services (P&LMS). The period of service … (show all)
is October 1, 2025, to September 30, 2026, with four consecutive option years. Services will be provided by the Contractor at both the Contractor s facility and on-site at WCHCS. WCHCS does not have an Anatomic Pathology department and needs a service that will provide a licensed consulting pathologist for surgical specimen processing with interpretation, cytological specimen processing with interpretation, and autopsy services. The Contractor shall provide all labor, supplies, equipment, maintenance, information technology, and supervision necessary to provide reference laboratory services to the WCHCS described herein. Contractor shall also have an existing VISTA connection. Reference laboratory services include, but are not limited to: specimen preparation and storage. transportation of clinical laboratory specimens, microbiology cultures, and stocks; performance of analytical testing; reporting of analytical test results; consultative services. Quality control activities. All Contractor s testing shall be executed in accordance with standard industry practices. It is preferred that test methods are FDA approved. Any non-FDA approved method being performed shall have a disclaimer and documented validation plan. Upon request, the validation plan and validation results shall be made available to the Contracting Officer s Representative (COR). The Contractor shall ensure the accurate and timely performance of laboratory testing services on all biomedical materials. Specimen Testing The Contractor shall pick up, process, embed, stain, cut, and coverslip the specimens, provide pathological analysis, and report findings in a reasonable time frame, as noted below. Surgical specimens shall be reported in less than or equal to two (2) days. Procedures include, but are not limited to, the following (by CPT code) performed at the Contractor s laboratory: 85060: Blood Smear, Peripheral, Interpretation by Physician 85097: Bone Marrow, Smear Interpretation 87624: Infectious Agent Detection by Nucleic Acid (DNA or RNA) 88164: Cytopathology, Slides, Cervical or Vaginal 88300: Level 1 Tissue Exam By Pathologist 88302: Level 2 Tissue Exam By Pathologist 88304: Level 3 Tissue Exam By Pathologist 88305: Level 4 Tissue Exam By Pathologist 88307: Level 5 Tissue Exam By Pathologist 88309: Level 6 Tissue Exam By Pathologist 88311: Decalcification Procedure 88312: Special Stains Group 1, including Interpretation and Report 88313: Special Stains Group 2, including Interpretation and Report 88321: Consultation and Report on Referred Slides Prepared 88323: Consultation and Report on Referred Material 88341: Immunohistochemistry or Immunocytochemistry, per Specimen 88342: Immunohistochemistry or Immunocytochemistry + Immunoperoxidase Stain 89060: Crystal Identification by Light Microscopy Non-GYN Cytology Specimens. Shall be reported in less than two (2) business days. Procedures include, but are not limited to, the following (by CPT code) performed at the Contractors laboratory: 88108: Cytopathology Concentration Technique 88112: Cytopathology, Selective Cellular Enhancement Technique GYN Cytology Specimens. Shall be reported in less than two (2) days. Procedures include, but are not limited to, the following (by CPT code) performed at the Contractors laboratory: 88141: Cytopathology, Cervical or Vaginal, GYN Physician Interpretation 88142: Cytopathology, Cervical or Vaginal, GYN auto Frozen Sections. Shall be processed and the initial report received at WCHCS within 20 minutes or less from the time the specimen is received at the Contractor s place of business. Procedures include, but are not limited to, the following (by CPT code) performed at the Contractors laboratory: 88331: Pathology Consultation During Surgery, Frozen Section 88332: Pathology Consultation During Surgery, Frozen Section Add Rush Block Fine Needle Aspirates. Immediate evaluations are performed at bedside at WCHCS for Fine Needle Aspirates and Core Biopsies to determine if the specimens are adequate and to provide a preliminary report. Specimens are then treated as surgical and Non-GYN cytology specimens. Procedures include, but are not limited to the following (by CPT code): 88172: Cytopathology, Evaluation of Fine Needle Aspirate + Fine Needle Consult 88173: Cytopathology, Evaluation of Fine Needle Aspirate 88333: Pathology Consultation During Surgery, Cytologic Examination + Misc. AP test Autopsies. Shall be processed and completed within sixty (60) days. A provisional diagnosis shall be received within two (2) business days. A post-mortem Quality Assurance Survey must be completed within thirty (30) days. Procedures include, but are not limited to, the following (by CPT code) performed at the Contractors laboratory: 88020: Necropsy (Autopsy), Limited, Gross and/or Microscopic, Without CNS 88025: Necropsy (Autopsy), Gross and Microscopic, with brain 88036: Necropsy (Autopsy), Limited, Gross and/or Microscopic Histology. The contractor shall embed, stain, cut, and coverslip to the specimens and then return the specimen to WCHCS. This could be called a Block and stain service for Anatomic pathology specimens should a special circumstance arise. Staining. Upon receipt of tissue specimens, the Contractor shall embed, perform a Hematoxylin & Eosin (H&E) stain, perform a single cut of the specimen, and affix it so a slide with coverslip. Staining. Upon receipt of tissue specimens, the Contractor shall embed, perform a Hematoxylin & Eosin (H&E) stain, perform a single cut of the specimen, and affix it so a slide with coverslip. NOTE: The Contractor must offer the Technical Component separately form the Professional Component on both their test menu and the bill of charges. NOTE: New tests not listed must be added to the contract though modification by the Contracting Officer prior to the specimen being tested. The Contractor shall notify the Contracting Officer and the Contracting Officer s Representative (COR) or designee of any test information modifications no earlier than two weeks prior to the desired implementation date of the test change. Specimen Preparation, Storage, and Retention for Reference Testing Specimens The Contractor shall provide all materials necessary to collect and preserve specimens that are destined to the commercial reference laboratory for testing. These materials include those items that are dictated by and in compliance with the collection requirements of the commercial reference laboratory. The Contractor shall be responsible for storing specimens in such a manner to ensure the integrity of the specimen. All Anatomic Pathology materials (e.g., histology blocks, slides or other diagnostic material) generated by the VA shall be returned within 2 days after final diagnosis is reported. The Contractor shall be responsible for storing specimens in such a manner to ensure the integrity of the specimen. Transportation Services for Reference Testing Specimens The Contractor shall provide transportation of primarily biomedical materials that include patient specimens, originating from the WCHCHS and destined to their contracted reference laboratory facility. These items are classified as Hazard Materials Class 6, Division 6.2 and are defined in 49 CFR Part 173.134 as those materials that contain or could contain etiologic agents. Transportation shall be done in such a manner that the safety and in
Who won similar work
4 award notices on SAM.gov in the last 24 months. Matched by: Same office (NETWORK CONTRACT OFFICE 19 (36C259)), same NAICS 621511.
Single-winner award sizes (4): middle half $595K to $1.0M, median $820K; range $486K to $1.1M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| EXOSOME DIAGNOSTICS INC · $TECH · $1.2B | 1 | $1.1M | Sep 16, 2026 |
| CYTOPATH BIOPSY LAB INC | 1 | $1.0M | Sep 22, 2026 |
| KASHI CLINICAL LABORATORIES, LLC | 1 | $632K | Feb 27, 2026 |
| VERACYTE LABS SD CORPORATION · $VCYT · $561.9M | 1 | $486K | May 29, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $TECH reported $1.2B revenue (fiscal year ending Jun 30, 2026). The median single-winner award in these 4 past awards, $820K, is under 0.1% of that. SEC filing
- $VCYT reported $561.9M revenue (12 months to Jun 30, 2026). The median single-winner award in these 4 past awards, $820K, is 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Sep 22, 2026CYTOPATH BIOPSY LAB INC$1.0MQ301-- Molecular Thyroid TestingNo listed company matched (Materiality N/A)
- Sep 16, 2026EXOSOME DIAGNOSTICS INC$1.1MQ301--Base Year | 36C259-26-AP-1918 | Prostate Testing Non-Invasive | VISN ContractMateriality: 0.09% of $TECH revenue (Low) SEC
- May 29, 2026VERACYTE LABS SD CORPORATION$486KQ301--5 Year BPA Decipher Prostate TestMateriality: 0.09% of $VCYT revenue (Low) SEC
- Feb 27, 2026KASHI CLINICAL LABORATORIES, LLC$632KQ515--Five Year Blanket Purchase Agreement Salt Lake City Heart and Kidney Transplant Rejection Test Services and ReportingNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 3 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.